ReviewCells2020
CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review.
Linn Amanda Syding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it
ReviewCells2020
Linn Amanda Syding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.